Morphogenesis Awarded SBIR Funding for Cervical Cancer Therapy
UF startup and UF Innovate | Sid Martin Biotech alum Morphogenesis, Inc., a clinical-stage biotechnology company, has obtained funding to develop a new therapeutic drug to treat cervical cancer.
UF Researchers Say Marine Products Show Promising Future In Medical Advancements
Many drug research efforts occurring at UF are focused on marine and natural products that will lead to advancements in medications and treatments for cancers. Dr. Hendrik Luesch was involved in a recent discovery of a marine compound off the east coast of Florida named gatorbulin-1 that could potentially be used in the fight against cancer; this discovery highlights the importance of searching the ocean’s biodiversity.
Dialectic Therapeutics Receives FDA Clearance of IND Application for for Its Lead Product Candidate To Treat Cancer
UF startup Dialectic Therapeutics, Inc., a Texas-based biotechnology company focused on creating innovative new technologies to treat cancer, announced that the U.S. Food and Drug Administration (FDA) has concluded that Dialectic may proceed with its clinical investigation for its lead product candidate, DT2216, a unique compound built using its proprietary and novel Antiapoptotic Protein Targeted Degradation (APTaD) technology.
UF Researchers Discover Marine Natural Product off Florida’s Coast That Could Help Fight Cancer
University of Florida researchers have discovered a novel marine natural product that binds to a new site of tubulin, an important target for cancer drugs.
UF Health Virtual Human Intervention Allows for Colorectal Cancer Screening From Home
A new University of Florida Health intervention gives patients who qualify access to colorectal cancer screening information and tests from the comfort of their own homes.
DNAtrix Announces Preclinical Data Demonstrating Anti-Tumor Activity of DNX-2401 in Models of Pediatric Tumors Published in Clinical Cancer Research
UF startup DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced preclinical data evaluating the use of DNX-2401 against the pediatric brain malignancies atypical teratoid/rhabdoid tumor (AT/RT) and primitive neuroectodermal tumors (PNETs) was published in Clinical Cancer Research.
UF Researcher Will Lead CureSearch for Children’s Cancer $1 Million Gift To Support Cutting-Edge Immunotherapy Trial for Pediatric High-Grade Glioma
CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors. The project is funded through a CureSearch Catapult Award granted to pediatric oncologist Elias Sayour, MD, Ph.D. at the University of Florida.
Dr. Merry Jennifer Markham Elected to ASCO Nominating Committee
Merry Jennifer Markham, M.D., FACP, FASCO, associate director for medical affairs at the UF Health Cancer Center and professor in the UF Division of Hematology and Oncology, has been elected to the American Society of Clinical Oncology (ASCO) Nominating Committee.
Patricia Lawman Develops Novel Cell and Gene Therapies to Fight Cancer
Patricia Lawman is on a mission to change the future of cancer care. After losing her parents to lung cancer and lymphoma, respectively, she recognized the detrimental impact of radiation and chemotherapy. She knew there must be a way to treat a patient’s cancer without the risk of toxicity and other negative side effects. After […]
What if You Could Take Cancer Cells and Make Them Into the Therapy?
This discovery gives cancer a one-two punch Cancer is the second leading cause of death in America and is the singular focus of research labs across the globe – with so much brain power tackling this problem, why does the solution remain elusive? Unfortunately, cancer isn’t just one thing: it can take many different forms […]